K101312 is an FDA 510(k) clearance for the NUVUE COLORMARK9TM) NEEDLE. Classified as System, Imaging, Pulsed Doppler, Ultrasonic within the IYN classification (a category covering pulsed Doppler and ultrasound imaging systems), Class II - Special Controls.
Submitted by Nuvue Therapeutics, Inc. (Fairfax, US). The FDA issued a Cleared decision on February 4, 2011 after a review of 269 days - an extended review cycle.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1550 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.
View all Nuvue Therapeutics, Inc. devices